Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 5915
TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100291(US8501744, 7)
Affinity DataKi:  0.350nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100304(US8501744, 29)
Affinity DataKi:  0.400nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100305(US8501744, 30)
Affinity DataKi:  0.450nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100296(US8501744, 17)
Affinity DataKi:  0.450nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100295(US8501744, 22)
Affinity DataKi:  0.600nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100294(US8501744, 16)
Affinity DataKi:  0.700nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100297(US8501744, 18)
Affinity DataKi:  0.700nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100289(US8501744, 5)
Affinity DataKi:  0.75nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100301(US8501744, 26)
Affinity DataKi:  0.800nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100293(US8501744, 12)
Affinity DataKi:  0.800nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100300(US8501744, 25)
Affinity DataKi:  0.800nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100288(US8501744, 4)
Affinity DataKi:  1nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100290(US8501744, 6)
Affinity DataKi:  1.10nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100302(US8501744, 27)
Affinity DataKi:  1.20nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100287(US8501744, 2)
Affinity DataKi:  1.5nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100303(US8501744, 28)
Affinity DataKi:  1.5nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100292(US8501744, 8)
Affinity DataKi:  1.70nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100286(US8501744, 1)
Affinity DataKi:  2.5nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100299(US8501744, 24)
Affinity DataKi:  3.20nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100298(US8501744, 23)
Affinity DataKi:  4.40nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100285(CAC1 proteinases 5,5 bicyclic inhibitor 10)
Affinity DataKi:  8.70nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM100284(CAC1 proteinases 5,5 bicyclic inhibitor 45a)
Affinity DataKi:  87.4nMAssay Description:In vitro cathepsin inhibition assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/30/2013
Entry Details
Go to US Patent